Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 7 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

7Total

Not Applicable (2)

P 1 (1)

P 2 (2)

P 3 (1)

P 4 (1)

Trial Status

Completed5

Active Not Recruiting1

Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT06441253Not ApplicableActive Not RecruitingPrimary

Development and Evaluation of a Portable Wedge Device for Calf Stretching to Alleviate Strain and Spasms

NCT03570671Not ApplicableUnknownPrimary

Noninvasive Cardiac Imaging in Vasospastic Angina Korean Registry (NAVIGATOR)

NCT02814565Phase 3Completed

Cyclobenzaprine HCl Extended Release 15 mg Versus Placebo in Treatment of Cervical and/or Lower Back Pain Due to Muscle Spasms of Local Origin

NCT01155167Phase 2Completed

Topical Radial Artery Vasodilation

NCT00246389Phase 4Completed

An Effectiveness and Safety Study of Cyclobenzaprine HCl Alone or in Combination With Ibuprofen for Acute Back or Neck Muscle Pain With Muscle Spasm

NCT00001784Phase 2Completed

Mexiletine for the Treatment of Focal Dystonia

NCT00001550Phase 1Completed

Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)

Showing all 7 trials

Spasm